Cargando…

Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications

Background: Many studies have evaluated the association between matrix metalloproteinase 9 (MMP9) gene promoter polymorphism and diabetic microvascular complications. However, the results are conflicting and inconclusive. The aim of this meta-analysis was to evaluate the association more precisely....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhongwen, Wu, Xiaoyun, Cai, Tian, Gao, Weiyi, Zhou, Xiaojun, Zhao, Junyu, Yao, Jinming, Shang, Hongxia, Dong, Jianjun, Liao, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515707/ https://www.ncbi.nlm.nih.gov/pubmed/26184271 http://dx.doi.org/10.3390/ijerph120708023

Ejemplares similares

Genetic Variants in Matrix Metalloproteinases MMP3 (rs3025058) and MMP9 (rs3918242) Associated with Colonic Diverticulosis
por: Nehring, Piotr, et al.
Publicado: (2023)

Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease
por: Xu, Yuanyuan, et al.
Publicado: (2017)

MMP9 Gene Polymorphism (rs3918242) Increases the Risk of Cardiovascular Disease in Type 2 Diabetes Patients
por: Buraczynska, Monika, et al.
Publicado: (2023)

Association of chemokine ligand 5/chemokine receptor 5 gene promoter polymorphisms with diabetic microvascular complications: A meta‐analysis
por: Zhang, Zhongwen, et al.
Publicado: (2015)

Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
por: Watson, Chris, et al.
Publicado: (2021)

Analysis of MMP-2-735C/T (rs2285053) and MMP-9-1562C/T (rs3918242) Polymorphisms in the Risk Assessment of Developing Lung Cancer
por: Wadowska, Katarzyna, et al.
Publicado: (2023)

MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese
por: Hsiao, Fu-Chih, et al.
Publicado: (2016)

Matrix Metalloproteinase-2 (MMP-2) and-9 (MMP-9) Gene Variants and Microvascular Complications in Type 2 Diabetes Patients
por: Andjelic, Jelic M, et al.
Publicado: (2023)

Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials
por: Shen, Xue, et al.
Publicado: (2016)

Chemokine Receptor 5, a Double-Edged Sword in Metabolic Syndrome and Cardiovascular Disease
por: Zhang, Zhongwen, et al.
Publicado: (2020)

Injection of Matrix Metalloproteinase-9 Leads to Ventricular Remodeling
por: Zhu, Enzheng, et al.
Publicado: (2022)

Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer
por: Shang, Hongxia, et al.
Publicado: (2020)

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cerebral infarction following urokinase thrombolysis in rats☆
por: Song, Yuqiang, et al.
Publicado: (2012)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Abnormal Expression of Matrix Metalloproteinase-9 (MMP9) Correlates with Clinical Course in Chinese Patients with Endometrial Cancer
por: Yu, Fang, et al.
Publicado: (2012)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Association of matrix metalloproteinase‐9 and nitric oxide with hypertension in obstructive sleep apnea
por: Zeng, Shiying, et al.
Publicado: (2022)

Matrix metalloproteinase-9 in relation to patients with complications after colorectal surgery: a systematic review
por: Edomskis, Pim, et al.
Publicado: (2020)

Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
por: Shang, Hongxia, et al.
Publicado: (2019)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis
por: Barbe, Adrian Mykhailovych, et al.
Publicado: (2020)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Matrix Metalloproteinases in Cardioembolic Stroke: From Background to Complications
por: Wysocka, Anna, et al.
Publicado: (2023)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
por: Kim, Wan-Uk, et al.
Publicado: (2005)

Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis
por: Wang, Ling-Feng, et al.
Publicado: (2010)

Matrix-metalloproteinase-9 is cleaved and activated by Cathepsin K
por: Christensen, Jon, et al.
Publicado: (2015)

The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020)

Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression
por: Li, Hongmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tlvt93imr0jolqneia780jkqde